Latest Technology News

Optiscan Imaging has lodged a US FDA 510(k) application for InVue, its precision surgery device designed to provide cellular-level imaging during operations. The submission moves the technology into formal regulatory review, but clearance and commercialisation remain uncertain.

Aurora Labs has appointed Andrew Garth as chief executive, moving former CEO Rebekah Letheby into a newly focused chief operating role. The reshuffle is intended to separate commercial strategy from technical execution as the company pursues scaled manufacturing and defence opportunities.

AdAlta and Shanghai Cell Therapy Group have approved the FDA briefing pack and manufacturing transfer plan for EW-001, bringing the mesothelioma CAR-T therapy closer to an Australian Phase 1 trial. The FDA meeting is scheduled for November, while two Chinese patients remain under follow-up, including a second complete responder.

First Graphene has signed a three-year agreement with Turkish manufacturer Aeropreg to develop and potentially commercialise PureGRAPH-enhanced carbon fibre prepreg. The partnership offers a clearer route into aerospace, defence and automotive supply chains, but commercial launch remains dependent on trial results.

Being AI is preparing to transfer 57% of its issued shares to existing shareholders while moving a 14.4% stake to Excalibur Capital Partners. The transactions are due to complete on 12 October, when the company will also receive a new chair and board.

FirstWave Cloud Technology has secured an approximately A$1.06 million placement to fund sales conversion and the launch of Open-AudIT 7 and an AI fault-diagnosis product. The raise follows a sharp reduction in losses, positive operating cash flow and a lower cost base, but adds about 151.3 million shares to the register.

6K Additive has completed a six-year, US$27.4 million secured loan with the US Export-Import Bank to expand production of critical metal powders in Pennsylvania. The financing gives the company access to project funding through June 2028, but the final interest rate and the expansion’s eventual output remain to be established.

Rubicon Water has told ASX that the selection of a joint venture bid containing about A$12 million of its technology was price-sensitive information. The company said it only learned of the decision when it appeared on Morocco’s procurement portal, then lodged its announcement after an overnight review and a four-second technical delay.

Stakk has executed a five-year US$9 million agreement with US banking technology provider Candescent, with its AI-powered cheque and document intelligence already deployed. The contract commits approximately US$1.8 million in annual revenue through 2030 and is expected to contribute above Stakk’s FY2027 revenue milestone.

Aeris Environmental’s FY2026 annual report pairs international commercial progress with a $5.03 million operating cash drain, $9.22 million in net liabilities and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company says it will need extended related-party loan terms and further funding while converting its technology and chemicals pipeline into recurring revenue.

xReality Group has identified unaudited adjustments that deepen its FY26 loss by $5.79 million and cut net assets from $14.0 million to $6.7 million. Customer revenue and cash flow are unchanged, but trading is suspended until the audit and amended accounts are completed.

Optiscan Imaging has lodged a 510(k) submission for its InForm digital pathology device, moving the product from development into formal US regulatory assessment. FDA clearance is not assured, but a successful determination could open the door to commercial distribution in the company’s target market.